Every Cure

About Every Cure

Every Cure is dedicated to saving and improving lives by repurposing existing drugs to treat diseases without cures. They aim to unlock the hidden potential of these drugs using a proven AI approach to analyze global knowledge of drugs and diseases, focusing on patient impact.

Products & Services

Drug Repurposing:Utilizing AI to identify and advance promising drug repurposing opportunities for diseases without approved treatments.

Specialties

Drug Repurposing Artificial Intelligence (AI) in Healthcare Drug Discovery Data Science Clinical Research

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 60000000 MR: - FA: 60 million FAN: 60000000	D: 2024-10-09 FD: 2024-10-09	10 investors
2	RT: Contract T: - FT: Contract	A: 48300000 MR: - FA: $48.3M FAN: 48300000	D: 2024-02-28 FD: 2024-02-28	1 investors

Grant Latest

2024-10-09

$60.0M

10 investors (Pro only)

Contract 2024-02-28

$48.3M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Adam Kolom

Biotech entrepreneur and private equity investor

A

Alexander Tropsha

K. H. Lee Distinguished Professor

A

Annalisa Jenkins

Life Sciences Thought Leader

B

Bing Chen

Executive Chairman and Founder

B

Bob Lord

Global Executive Leader

B

Brenda Cooperstone

MD

View 85 more team members with Pro

Unlock Full Team Directory

Recent News

Every Cure Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised